Compare CIVB & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIVB | MLAB |
|---|---|---|
| Founded | 1884 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 591.5M | 533.0M |
| IPO Year | 2012 | 1995 |
| Metric | CIVB | MLAB |
|---|---|---|
| Price | $28.76 | $96.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $26.60 | ★ $94.00 |
| AVG Volume (30 Days) | 156.3K | ★ 182.2K |
| Earning Date | 04-22-2026 | 05-27-2026 |
| Dividend Yield | ★ 2.90% | 0.67% |
| EPS Growth | 31.34 | ★ 436.11 |
| EPS | 0.72 | ★ 1.21 |
| Revenue | ★ $19,023,000.00 | N/A |
| Revenue This Year | $14.88 | $6.07 |
| Revenue Next Year | $5.99 | $5.41 |
| P/E Ratio | ★ $39.65 | $80.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.95 | $59.63 |
| 52 Week High | $29.38 | $113.99 |
| Indicator | CIVB | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 47.44 |
| Support Level | $26.21 | $94.01 |
| Resistance Level | $29.38 | $97.56 |
| Average True Range (ATR) | 0.82 | 4.74 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 75.62 | 38.33 |
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.